Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Hematology

Gamida Cell Presents Omidubicel Phase 3 Data in Patients with High-Risk Hematologic Malignancies

Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]

Gamida Cell Presents Omidubicel Phase 3 Data in Patients with High-Risk Hematologic Malignancies
3 weeks ago
Share

AstraZeneca’s Calquence Meets Primary Efficacy Endpoint in Head-to-Head Trial Against Ibrutinib in Chronic Lymphocytic Leukemia

AstraZeneca reported positive results from the phase 3 ELEVATE-RR trial, which evaluated AstraZeneca’s Calquence (acalabrutinib) versus ibrutinib in adults with previously treated, […]

AstraZeneca’s Calquence Meets Primary Efficacy Endpoint in Head-to-Head Trial Against Ibrutinib in Chronic Lymphocytic Leukemia
1 month ago
Share

Agios Reports Data from Phase 3 ACTIVATE-T Trial of Mitapivat in Regularly Transfused Adults with PK Deficiency

Agios Pharmaceuticals  announced results from the phase 3 ACTIVATE-T trial of mitapivat in regularly transfused adults with Pyruvate Kinase (PK) deficiency. […]

Agios Reports Data from Phase 3 ACTIVATE-T Trial of Mitapivat in Regularly Transfused Adults with PK Deficiency
1 month ago
Share

BioMarin Reports Top-Line Results from Phase 3 Gene Therapy Study in Adults with Hemophilia A

BioMarin announced positive topline results from its ongoing global Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy […]

BioMarin Reports Top-Line Results from Phase 3 Gene Therapy Study in Adults with Hemophilia A
2 months ago
Share

Constellation Pharma Reports Initial Data from MANIFEST Trials of CPI-0610 for Myelofibrosis

Constellation Pharmaceuticals announced positive preliminary data from its Phase II MANIFEST and Phase III MANIFEST-2 clinical trials evaluating CPI-0610 for […]

Constellation Pharma Reports Initial Data from MANIFEST Trials of CPI-0610 for Myelofibrosis
3 months ago
Share

Baylor College of Medicine Secures $1.4m to Fund a CAR T Cell-based Clinical Trial Investigating Advanced Sarcoma in Children

A Baylor College of Medicine and Texas Children’s Cancer Center research team has been awarded a $1.4 million gift over […]

Baylor College of Medicine Secures $1.4m to Fund a CAR T Cell-based Clinical Trial Investigating Advanced Sarcoma in Children
3 months ago
Share

uniQure Reports Positive Top-Line Data from HOPE-B Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B

Uniqure announced positive top-line data from its pivotal, Phase III HOPE-B gene therapy trial of etranacogene dezaparvovec, an adeno-associated virus five […]

uniQure Reports Positive Top-Line Data from HOPE-B Trial of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B
4 months ago
Share

GenMab’s Daratumumab Slows Multiple Myeloma Disease Progression in Phase 3 CASSIOPEIA Trial

GenMab announced positive topline results from the second part of the Phase 3 CASSIOPEIA (MMY3006) study of daratumumab monotherapy as […]

GenMab’s Daratumumab Slows Multiple Myeloma Disease Progression in Phase 3 CASSIOPEIA Trial
4 months ago
Share

UT Southwestern Investigators Head Nationwide Studies Investigating Childhood Blood Disorders

UT Southwestern research shows the effectiveness of a treatment for aplastic anemia while revealing a range of diagnosis and treatment […]

UT Southwestern Investigators Head Nationwide Studies Investigating Childhood Blood Disorders
5 months ago
Share

Astex and Otsuka Announce Phase 3 ASTRAL-2 and ASTRAL-3 Studies Fail to Meet Endpoints in Patients with Previously Treated AML and MDS

Astex Pharmaceuticals and Otsuka Pharmaceuticals announced top-line results of the ASTRAL-2 and ASTRAL-3 clinical studies that evaluated the efficacy and […]

Astex and Otsuka Announce Phase 3 ASTRAL-2 and ASTRAL-3 Studies Fail to Meet Endpoints in Patients with Previously Treated AML and MDS
5 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.